OrthoPediatrics Corp. (NASDAQ:KIDS) Stock Has Average Target Price of $26.50

Shares of OrthoPediatrics Corp. (NASDAQ:KIDS) have been given a consensus rating of “Moderate Buy” by the seven analysts that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and five have issued a buy rating on the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $26.50.

A number of research firms have commented on KIDS. Weiss Ratings upgraded shares of OrthoPediatrics from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, August 5th. BTIG Research reissued a “buy” rating and issued a $29.00 target price on shares of OrthoPediatrics in a research report on Monday, September 14th. Truist Financial upgraded OrthoPediatrics to a “hold” rating in a report on Thursday, October 1st. Piper Sandler reiterated an “overweight” rating and set a $25.00 price objective (up from $22.00) on shares of OrthoPediatrics in a research note on Wednesday, August 5th. Finally, Needham & Company LLC raised their target price on OrthoPediatrics from $30.00 to $35.00 and gave the company a “buy” rating in a research note on Wednesday, August 5th.

Insider Buying and Selling

In other news, Director David R. Pelizzon sold 302,369 shares of OrthoPediatrics stock in a transaction on Thursday, September 10th. The stock was sold at an average price of $21.01, for a total transaction of $6,352,772.69. Following the transaction, the director directly owned 6,201,764 shares in the company, valued at approximately $130,299,061.64. This trade represents a 4.65% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, major shareholder Jennifer N. Pritzker sold 302,369 shares of OrthoPediatrics stock in a transaction dated Thursday, September 10th. The stock was sold at an average price of $21.01, for a total value of $6,352,772.69. Following the transaction, the insider directly owned 6,201,764 shares in the company, valued at approximately $130,299,061.64. The trade was a 4.65% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 2,100,000 shares of company stock valued at $46,747,931 over the last 90 days. 32.50% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of KIDS. GAMMA Investing LLC lifted its holdings in shares of OrthoPediatrics by 70.3% during the third quarter. GAMMA Investing LLC now owns 1,165 shares of the company’s stock valued at $26,000 after purchasing an additional 481 shares during the last quarter. Squarepoint Ops LLC boosted its stake in OrthoPediatrics by 95.0% in the 2nd quarter. Squarepoint Ops LLC now owns 195,468 shares of the company’s stock worth $3,739,000 after purchasing an additional 95,230 shares during the period. Waverly Advisors LLC grew its position in OrthoPediatrics by 6.7% during the 2nd quarter. Waverly Advisors LLC now owns 12,366 shares of the company’s stock worth $237,000 after purchasing an additional 775 shares in the last quarter. Nantahala Capital Management LLC acquired a new stake in OrthoPediatrics during the 2nd quarter valued at $4,636,002. Finally, Grandeur Peak Global Advisors LLC acquired a new stake in OrthoPediatrics during the 2nd quarter valued at $954,000. Institutional investors own 69.05% of the company’s stock.

OrthoPediatrics Price Performance

Shares of NASDAQ KIDS opened at $22.25 on Thursday. OrthoPediatrics has a fifty-two week low of $14.42 and a fifty-two week high of $26.74. The business has a 50 day moving average price of $23.10 and a two-hundred day moving average price of $19.86. The company has a quick ratio of 2.17, a current ratio of 4.78 and a debt-to-equity ratio of 0.28. The firm has a market cap of $580.95 million, a PE ratio of -13.24 and a beta of 0.99.

OrthoPediatrics (NASDAQ:KIDS) last released its quarterly earnings results on Tuesday, August 4th. The company reported ($0.26) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.30) by $0.04. The business had revenue of $70.51 million during the quarter, compared to the consensus estimate of $68.21 million. OrthoPediatrics had a negative net margin of 15.72% and a negative return on equity of 8.10%. Sell-side analysts expect that OrthoPediatrics will post -1.14 earnings per share for the current fiscal year.

OrthoPediatrics Company Profile

OrthoPediatrics Corp. is a medical device company focused exclusively on developing and commercializing orthopedic products for children. Headquartered in Warsaw, Indiana, the company designs implants and instruments intended to address the distinct anatomical and clinical needs of pediatric patients, including those whose bones are still growing.

Its product portfolio includes systems for pediatric trauma and deformity correction, scoliosis treatment, limb reconstruction, and pediatric sports medicine.